H

Hologic
D

HOLX

69.730
USD
-0.23
(-0.33%)
مغلق
حجم التداول
103,806
الربح لكل سهم
4
العائد الربحي
-
P/E
21
حجم السوق
15,824,611,061
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    -0.420
    (-0.37%)
    113.490 USD
    B
    BAX
    0.020
    (0.06%)
    30.970 USD
    BDX
    BDX
    1.040
    (0.44%)
    237.340 USD
    D
    DGX
    -0.444
    (-0.29%)
    151.211 USD
    EW
    EW
    -0.080
    (-0.11%)
    69.790 USD
    ISRG
    ISRG
    8.60
    (1.47%)
    592.67 USD
    MDT
    MDT
    0.920
    (1.06%)
    88.090 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    SYK
    SYK
    1.63
    (0.43%)
    383.42 USD
    TMO
    TMO
    -1.98
    (-0.35%)
    559.67 USD
    المزيد
الأخبار
المقالات

العنوان: Hologic

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.